Status:
COMPLETED
A Study of LY2623091 in Healthy Participants
Lead Sponsor:
Eli Lilly and Company
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The first purpose of this study is to evaluate the effect of itraconazole (and possibly diltiazem) on the amount of LY2623091 in the blood stream and how long the body takes to get rid of it. The sec...
Eligibility Criteria
Inclusion
- Healthy participants as determined by medical history, physical examination, clinical laboratory tests, and electrocardiograms (ECGs).
- Have a body mass index (BMI) between 18 and 32.0 kilograms per square meter (kg/m\^2) inclusive, at screening
- Female participants must be of non-childbearing potential
Exclusion
- In the opinion of the investigator or sponsor, are unsuitable for inclusion in the study
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT02300259
Start Date
November 1 2014
End Date
April 1 2015
Last Update
June 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Covance Clinical Research Inc
Daytona Beach, Florida, United States, 32117